🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
The purpose of this study is to assess the effectiveness and safety of an a...
Status
Completed
Location
AlabamaTherapeutics CRS
Start Date
2009-04
Trial ID
NCT00830804
Treatments Being Tested
This study will assess and characterize the variability observed in the res...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2017-03-23
Trial ID
NCT03101644
Treatments Being Tested
The purpose of this study is to compare change of brachial artery flow medi...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01391013
Treatments Being Tested
The purpose of this study is to assess whether a boosting by cobicistat res...
Status
Terminated
Location
Division of Infectious Diseases, University Hospital Basel
Start Date
2015-07
Trial ID
NCT02503462
Treatments Being Tested
The purpose of this study is to characterise the pharmacokinetic profiles o...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2005-01
Trial ID
NCT00307502
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ...
Status
Completed
Location
Yarosslavl Clinical Hospital #3
Start Date
2019-06-06
Trial ID
NCT04268472
This is a pilot, proof of concept, open-label clinical trial, to assess the...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2012-05
Trial ID
NCT01480713
Treatments Being Tested
This will be an open-label, parallel group, multiple dose study in approxim...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-11-06
Trial ID
NCT02625207
Treatments Being Tested